The goal of this observational study is to evaluate the feasibility, safety, and effectiveness of a fully enclosed protective device system in laparoscopic myomectomy to achieve tumor-free protection throughout the entire surgical procedure in women aged 28-46 years diagnosed with uterine fibroids who require laparoscopic myomectomy.

The main questions it aims to answer are:

Can the fully enclosed protective device system successfully achieve complete physical isolation of fibroid tissue during laparoscopic myomectomy and morcellation?

Does the use of this device reduce the risk of tissue dissemination or leakage while maintaining acceptable surgical outcomes such as operative time, blood loss, and postoperative recovery?

Participants will undergo laparoscopic myomectomy assisted by the fully enclosed protective device system. During the procedure, participants will:

undergo laparoscopic removal of uterine fibroids using a fully enclosed protective isolation system

have the fibroid dissected and contained within a protective bag during the entire procedure

receive in-bag morcellation or fragmentation of fibroid tissue within a sealed environment

be evaluated for operative outcomes including fibroid size, operative time, intraoperative blood loss, integrity of the protective bag, and postoperative hospital stay

Inclusion Criteria:

Female patients aged 28 to 46 years Diagnosis of uterine fibroids confirmed by pelvic ultrasound and magnetic resonance imaging (MRI) Maximum diameter of the dominant fibroid between 6 and 10 cm Scheduled to undergo laparoscopic myomectomy Preoperative evaluation consistent with benign uterine fibroids Able and willing to provide written informed consent

Exclusion Criteria:

Suspicion of uterine malignancy based on imaging findings or clinical assessment Presence of severe systemic disease contraindicating laparoscopic surgery Current pregnancy Inability or unwillingness to provide informed consent

The study population includes female patients with uterine fibroids undergoing laparoscopic myomectomy at a single center between April 2025 and March 2026. Eligible participants are women aged 28 to 46 years with fibroids measuring 6 to 10 cm in diameter and preoperative findings consistent with benign disease.

Individual participant data (IPD) from this study will not be publicly shared because the dataset contains identifiable clinical information from a small number of patients treated at a single institution. Public release of these data may increase the risk of patient re-identification and compromise participant privacy. In addition, the study was conducted as a retrospective analysis and the informed consent obtained from participants did not include permission for public sharing of individual-level data. Therefore, to protect patient confidentiality and comply with institutional ethics policies, IPD will not be made publicly available.